Channel BannerChannel Banner
vEg523BilxIvEg523BilxI

Vaccine safety update

252,935
Socialcounts.OrgEnter Fullscreen (f)
6,488
likes
3,503
comments
daily view 0
monthly view 0

Share

Live Analytics

Comments 0

Vaccine safety update Analytics Table

Income Estimates for Vaccine safety update

Based on this YouTube video's total view count of 252K views and industry-standard rates, the estimated total earning is $177 - $506 through ad revenue. Historical data is not yet available to calculate daily, weekly, or monthly averages.

About Vaccine safety update

Explore Vaccine safety update with 252,935 views, 6,488 likes, and 3,503 comments. Experience the impact of this video content that has captured audience attention.

EMA https://www.bbc.co.uk/news/world-europe-56665150 possibility of very rare cases of blood clots combined with low levels of blood platelets occurring within two weeks of vaccination 86 European cases plausible explanation for these rare side effects is an immune response to the vaccine 18 deaths Benefits of the vaccine outweighed the risk 25 million doses (One case per 290,697 doses) (One death per 1,388,888) Could not list specific risk factors such as age or gender, but most blood clot cases were women under 60 Emer Cooke No available evidence of specific risk factors such as age, gender, or previous medical history of clotting disorders This vaccine has proven to be highly effective - it prevents severe disease and hospitalisation, and it is saving lives. Belgium Restrict AstraZeneca to those aged 56 and above Italy Over 60s No evidence to stop people having a second dose of AstraZeneca Spain Restricting AstraZeneca to those between 60 and 64 France Given only to those aged 0ver 55 Germany Over 60s, plus high-priority groups Under-60s who have received an AstraZeneca first dose should get a different vaccine for their second Norway and Denmark Full suspension Germany also says its World Health Organization's advisory vaccine safety panel Blood clot link was plausible not confirmed very rare among 200 million people vaccinated with AstraZeneca globally Statement from the Joint Committee on Vaccination and Immunisation (JCVI) on the use of the AstraZeneca COVID-19 vaccine https://www.gov.uk/government/publications/use-of-the-astrazeneca-covid-19-vaccine-jcvi-statement Acting on a precautionary basis, if these persons (under 30) are still unvaccinated, it is preferable for them to be offered an alternative COVID-19 vaccine, if available. MHRA issues new advice, concluding a possible link between COVID-19 Vaccine AstraZeneca and extremely rare, unlikely to occur blood clots https://www.gov.uk/government/news/mhra-issues-new-advice-concluding-a-possible-link-between-covid-19-vaccine-astrazeneca-and-extremely-rare-unlikely-to-occur-blood-clots Slides from press conference https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/976877/CovidStats_07-04-21-final.pdf Medicines and Healthcare products Regulatory Agency (MHRA) Possible risk of extremely rare and unlikely to occur specific types of blood clots MHRA has undertaken a thorough review into UK reports Very rare and unlikely to occur, cerebral venous sinus thrombosis (CVST) Occurring together with low levels of platelets (thrombocytopenia) It is also considering other blood clotting cases (thromboembolic events) alongside low platelet levels Most presenting within 14 days of first dose Analysed by Commission on Human Medicines (CHM) https://www.gov.uk/government/organisations/commission-on-human-medicines/about/membership COVID-19 Vaccines Benefit Risk Expert Working Group Up to and including 31 March 2021 20.2 million doses of AstraZeneca had given in the UK Overall risk of these blood clots is approximately 4 people in a million (One in 255,696) MHRA had received 79 UK reports of blood clotting cases alongside low levels of platelets 44 of the 79 cases were of CVST with thrombocytopenia 35 of the 79 cases were of thrombosis in other major veins with thrombocytopenia 79 cases occurred in 51 women and 28 men, aged from 18 to 79 years 19 deaths (One in 1,063,157) 19 people have died out of the 79 cases, 13 females and 6 males 11 out of the 19 people who died were under the age of 50 3 of whom were under 30 14 of these 19 cases were of CVST with thrombocytopenia 5 of the 19 were thrombosis with thrombocytopenia All 79 cases occurred after a first dose of the vaccine UK CoViD deaths 8th April, + 53 = 126,980 or 149,968 Level of risk 31 March numbers, slightly higher than 24 March Anyone who did not have these side effects should have second dose Pregnancy predisposes to thrombosis, discuss with their healthcare professional Precautionary measure, seek prompt medical advice Shortness of breath, chest or persistent abdominal pain, leg swelling Blurred vision, confusion or seizures Pin-prick rash or bruising beyond the injection site New onset of severe or persistent headache that does not respond to simple painkillers starting four days or more after vaccination should speak to their doctor. Dr June Raine, MHRA Chief Executive Use Yellow Card Website https://coronavirus-yellowcard.mhra.gov.uk It is still vitally important that people come forward for their vaccination when invited to do so Advice for health care professionals https://www.gov.uk/government/publications/regulatory-approval-of-covid-19-vaccine-astrazeneca/information-for-healthcare-professionals-on-covid-19-vaccine-astrazeneca Following administration, the S glycoprotein of SARS CoV 2 is expressed locally stimulating neutralising antibody and cellular immune responses.

About YouTube Real-Time View Count

With SocialCounts.org’s view counter, track your YouTube video’s live view count and YouTube likes count in real time with fast, reliable updates.

Watch every YouTube video live view count rise with our real-time YouTube views tracker—built for accuracy and minimal delay.

Follow YouTube real time views as they happen, using our dedicated view counter for YouTube videos.

Get up-to-date live view count on YouTube and see real-time growth with SocialCounts.org’s smart tracking tools.

Embed Widget

Parameters:

  • fullscreen=true - Fullscreen counter
  • graph=true - Live graph chart
  • counter=0/1/2 - Select counter (0=likes, 1=views, 2=comments)
URL

Click to copy the embed URL to your clipboard